Multifocal progressive refractive diffractive lens: Optic design and clinical results [Multifokal progressif refraktif difraktif lens: Optik tasari{dotless}m ve klinik sonuçlari{dotless}]

Basit Öğe Kaydı
dc.authorid0000-0002-2918-1816en_US
dc.contributor.authorTunç Z.
dc.contributor.authorHelvacioglu F.
dc.contributor.authorŞencan S.
dc.contributor.authorŞimşek S.
dc.date.accessioned2024-07-12T21:53:47Z
dc.date.available2024-07-12T21:53:47Z
dc.date.issued2012en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractPurpose: To evaluate the visual functions of patients who had implantation of new-concept intraocular lens (IOL) OptiVis™, which has aspheric bifocal diffractive and progressive refractive design. Ma te ri al and Met hod: In this prospective study, 52 eyes of 27 patients had a new multifocal IOL OptiVis™ implantation through 2.5 mm incision after cataract surgery with phacoemulsification. 25 of the patients had simultaneous bilateral phacoemulsification with OptiVis™ IOL implantation. Two patients with different multifocal IOL previously implanted underwent monocular OptiVis™ implantation. Monocular distance, near and intermediate visual acuities and contrast sensitivity of the patients were recorded. Presence of glares and halo, frequency of spectacle use and patients' satisfaction were questioned. Re sults: The mean age of the patients was 71.10±10.60 years and the me an follow-up time was 20.35±13.99 months. The mean monocular uncorrected visual acuities of the patients were 0.96±0.11 (Snellen card in decimals) for distance, J1.07±0.26 (Jaeger card) for near (33 cm) and J2.25±0.55 for intermediate (60 cm) at 6 months after the operations. The mean best-corrected monocular visual acuities were 0.97±0.08, J1.05±0.23 and J2.23±0.54, respectively. The mean monocular contrast sensitivity of the patients under photic conditions were 47 in 1.5 cycles per degree (cpd), 73 in 3 cpd, 61 in 6 cpd, 17 in 12 cpd and 2 in 18 cpd. The halo and glare problems which were moderate at the first postoperative month, were mild or none in 20 patients (74.07%) and moderate in 7 patients (25.92%) at 3 months after the surgery. Only one patient (3.70%) sometimes needed glasses for far vision. Posterior capsule opacification was seen in 3 eyes (5.76%). Dis cus si on: OptiVis™, with its diffractive bifocal design, provided very good distance and near vision without any contrast loss. Additionally, this IOL provided considerably good intermediate vision with its progressive refractive design, thus resulted in high patient satisfaction.en_US
dc.identifier.doi10.4274/tjo.42.44366
dc.identifier.endpage331en_US
dc.identifier.issn1300-0659
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-84867968041en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage326en_US
dc.identifier.urihttps://dx.doi.org/10.4274/tjo.42.44366
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8541
dc.identifier.volume42en_US
dc.identifier.wosWOS:000219205600004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.relation.ispartofTurk Oftalmoloiji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY03659
dc.subjectCataracten_US
dc.subjectMultifocal apodized diffractive refractive intraocular lensesen_US
dc.subjectMultifocal intraocular lensen_US
dc.subjectOptivis™en_US
dc.subjectPhacoemulsificationen_US
dc.titleMultifocal progressive refractive diffractive lens: Optic design and clinical results [Multifokal progressif refraktif difraktif lens: Optik tasari{dotless}m ve klinik sonuçlari{dotless}]en_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu